The GREM1Mut, which we clearly demonstrated, does not bind to BMP2 in both HCT116 (Fig. 8C) and C2C12 cells (Fig. S1C) may be a valuable reagent to further refine our understanding of GREM1-RTK signaling in cancer and other diseases. The gene discussed is GREM1; the disease is cancer.